Genestra Brands Femagen TLI
Genestra Brands Femagen TLI, NPN 80021761: natural health product licensed in Canada. Medicinal ingredients: Fer, Niacine.
If this product were sold in France
- Declared dose above a limit
Fer: up to 30 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Fer Source : Carbonyl Iron | 30 mg | 30,000 µg |
| Niacine Source : Niacine | 30 mg | Not calculated |
Non-medicinal ingredients
Glycérine, Stéarate de magnésium, Silice, Croscarmellose de sodium, Hypromellose, Phosphate de calcium dibasique dihydraté, cellulose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 1 Tous les jours |
Uses authorised in Canada
A factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins; helps to form red blood cells and helps in their proper function. An antioxidant for the maintenance of good health; helps in the development and maintenance of bones, cartilage, teeth and gums; helps normal growth and development; helps in wound healing; helps in tissue and connective tissue formation and helps to repair connective tissue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contra-Indications
For adult use only. If you are pregnant or breastfeeding or if you have kidney, liver disease, Wilson's disease, hemochromatosis, or intestinal obstruction, do not use.
- Known Adverse Reactions
Some people may experience constipation, diarrhea and/or vomiting, flushing, burning, tingling or itching sensation on the face, arms or chest.
Product record
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80021761
- Status
- Active licence
- Licence date
- 15 October 2010
- Revision date
- 17 December 2015
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80021761
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Genestra Brands Femagen TLI (Seroyal International): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80021761-genestra-brands-femagen-tli, updated 17 December 2015.